The Cigna Group (CI)
| Market Cap | 74.63B -7.7% |
| Revenue (ttm) | 282.38B +7.8% |
| Net Income | 6.42B +27.9% |
| EPS | 24.18 +32.6% |
| Shares Out | 264.24M |
| PE Ratio | 11.62 |
| Forward PE | 8.85 |
| Dividend | $6.24 (2.21%) |
| Ex-Dividend Date | Sep 8, 2026 |
| Volume | 394,631 |
| Open | 281.16 |
| Previous Close | 281.03 |
| Day's Range | 280.46 - 287.89 |
| 52-Week Range | 239.51 - 312.18 |
| Beta | 0.30 |
| Analysts | Buy |
| Price Target | 342.29 (+21.19%) |
| Earnings Date | Nov 5, 2026 |
About CI
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. It operates through two segments: Evernorth Health Services and Cigna Healthcare. The Evernorth Health Services segment includes Pharmacy Benefit Services and Specialty and Care Services, offering pharmacy benefit management, drug claim adjudication, retail pharmacy network administration, benefit design consultation, drug utilization review, drug formulary management, pharmacy benefits, home delivery pharmacy, specialty p... [Read more]
Financial Performance
In 2025, The Cigna Group's revenue was $274.90 billion, an increase of 11.24% compared to the previous year's $247.12 billion. Earnings were $5.96 billion, an increase of 73.47%.
Financial StatementsAnalyst Summary
According to 24 analysts, the average rating for CI stock is "Buy." The 12-month stock price target is $342.29, which is an increase of 21.19% from the latest price.
News
The Cigna Group's Third Quarter 2026 Earnings Release Details
BLOOMFIELD, Conn., Oct. 9, 2026 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) will release its third quarter 2026 financial results on Thursday, November 5, 2026, and will host a con...
Cigna Healthcare Introduces Health Sense To Connect Guidance, Benefits and Clinical Support Around Each Person, Improving Affordability and Outcomes
By connecting information about each person's health, care and coverage, Health Sense℠ helps people receive continuous personalized support, make informed decisions and act sooner Projected to reduce ...
Cigna price target raised to $370 from $346 at Piper Sandler
Piper Sandler analyst Jessica Tassan raised the firm’s price target on Cigna (CI) to $370 from $346 and keeps an Overweight rating on the shares. The firm notes the company…
The Cigna Group Transcript: Investor Day 2026
Lead to One drives personalization at scale, focusing on complex care and leveraging AI, data, and integrated clinical capabilities. Specialty and Care is the fastest-growing segment, with the Signature model transforming Pharmacy Benefit Services. The company targets 10%-14% annual EPS growth through 2030, supported by $3B in efficiency savings and $50B in cash flow.
The Cigna Group Slides: FY 2026
The Cigna Group has posted slides in relation to its FY 2026 quarterly earnings report, which was published on September 30, 2026.
Cigna to invest $3 billion in multi-year initiative to improve workflow
Cigna said on Wednesday it will invest $3 billion as part of a multi-year program to focus on modernizing processes and streamlining workflows, among others, with AI-enabled insights and tools to d...
Cigna backs FY26 adjusted EPS view ‘at least’ $30.45, consensus $30.51
Backs FY26: Consolidated adjusted revenues about $280B, consensus $286.76B; Evernorth Health Services pre-tax adjusted income from operations of at least $6.90B; Cigna (CI) Healthcare pre-tax adjusted...
Cigna announces $3B multi-year modernization and productivity initiative
As part of its “Lead to One” vision, The Cigna (CI) Group is announcing a new $3B multi-year modernization and productivity initiative to support growth and financial performance. The initiatives…
The Cigna Group Hosts 2026 Investor Day; Introduces "Lead to One" to Drive Durable Growth Through Complex Care Leadership and Differentiated Capabilities
Following deliberate portfolio shaping over the last several years, The Cigna Group is strategically positioned where health care costs are concentrating with multiple avenues for growth Announces "Le...
Cigna Stock in Focus as Investor Day Spotlights Specialty Drugs
Cigna Group investors will be looking for more detail on the growth of its specialty pharmacy business under new CEO Brian Evanko.
Is Volunteering Good for Your Health? New Research From The Cigna Group Finds a Strong Connection
The Cigna Group's Vitality in America report finds people who volunteer feel healthier, more connected, and more resilient Research links employee volunteerism to higher job satisfaction, workplace pr...
The Cigna Group to Host Investor Day on September 30
BLOOMFIELD, Conn., Sept. 9, 2026 /PRNewswire/ -- Global health company The Cigna Group (NYSE: CI) will host its Investor Day on Wednesday, September 30, 2026.
Cigna initiated with an In Line at Evercore ISI
Evercore ISI analyst Elizabeth Anderson initiated coverage of Cigna (CI) with an In Line rating and $290 price target The pharmacy benefit manager is “undergoing a generational transformation” as it…
Cigna Healthcare Connects Medical and Supplemental Benefits To Help People Better Manage Unexpected Health Costs
Industry-first connected benefits experience helps people access cash benefits when they need it most and gives employers more affordable coverage options BLOOMFIELD, Conn., Aug. 26, 2026 /PRNewswire/...
Cigna downgraded to Hold from Buy at Jefferies
Jefferies downgraded Cigna (CI) to Hold from Buy with a price target of $307, down from $336. The firm believes consensus estimates for Cigna look a “little high” with the…
Cigna downgraded to Outperform from Strong Buy at Raymond James
Raymond James downgraded Cigna (CI) to Outperform from Strong Buy with a price target of $320, down from $350. Cigna is a slower-growth story with limited near-term catalysts, while PBM…
Cigna price target raised to $305 from $302 at Deutsche Bank
Deutsche Bank raised the firm’s price target on Cigna (CI) to $305 from $302 and keeps a Hold rating on the shares.
Cigna price target raised to $362 from $337 at Baird
Baird raised the firm’s price target on Cigna (CI) to $362 from $337 and keeps an Outperform rating on the shares. The firm updated its model following Q2 results and…
Cigna price target raised to $361 from $338 at Guggenheim
Guggenheim raised the firm’s price target on Cigna (CI) to $361 from $338 and keeps a Buy rating on the shares on higher 2027 estimates after Cigna reported Q2 EPS…
The Cigna Group Earnings Call Transcript: Q2 2026
Q2 2026 saw revenues of $71.7B and adjusted EPS of $7.78, with both Evernorth and Cigna Healthcare exceeding expectations. Full-year adjusted EPS guidance was raised to at least $30.45, driven by strong specialty growth, biosimilar adoption, and disciplined execution.
The Cigna Group Earnings release: Q2 2026
The Cigna Group released its Q2 2026 earnings on July 30, 2026, summarizing the period's financial results.
The Cigna Group Quarterly report: Q2 2026
The Cigna Group has published its Q2 2026 quarterly earnings report on July 30, 2026.
As New CEO Takes Charge, Cigna Reports $1.7 Billion Quarterly Profit
The Cigna Group Thursday reported second quarter net income of nearly $1.7 billion despite continued elevated medical costs dogging the entire health insurance industry.
Cigna Group Lifts Outlook, Logs Higher Profit on Growth Across Businesses
Cigna Group lifted its outlook and reported a higher profit in the second quarter, driven by growth in both its healthcare and pharmacy-benefit businesses.
Cigna raises annual profit forecast on strength in health services unit
Cigna on Thursday raised its annual profit forecast, after beating quarterly earnings estimates on growth in its pharmacy and specialty drug businesses.